On May, 16 Cantel Medical Corp. (CMD) Reached 12-Month High at $127.67

May 16, 2018 - By Mary Kidd

Cantel Medical Corp. (NYSE:CMD) having $127.67 price per share and $139.16 price target broke into 52 week high. It was announced on May, 16 by Barchart.com. The company has $5.33B MC. The valuation of NYSE:CMD can change by $479.34M if our $139.16 price target is broke into.

Ticker’s shares touched $127.67 during the last trading session after 2.23% change.Currently Cantel Medical Corp. is uptrending after 41.41% change in last May 16, 2017. CMD has 161,870 shares volume. CMD outperformed by 29.86% the S&P 500.

On May, 31 WallStreet anticipated Cantel Medical Corp. (NYSE:CMD)’s earnings report, RTT reports. Analysts predict $0.60 earnings per share, which is $0.09 up or 17.65 % from 2017’s $0.51 earnings per share. CMD’s profit could reach $25.03M with 53.20 P/E in case $0.60 earnings per share is published. After $0.59 EPS report previous quarter, Wall Street now sees 1.69 % EPS growth of Cantel Medical Corp..

There’s an important Cantel Medical Corp. (NYSE:CMD) news released by Benzinga.com. It’s an article titled: “Jim Cramer Weighs In On Align Technology, Berkshire Hathaway, Symantec And More” on May 15, 2018.

Cantel Medical Corp. provides infection prevention services and products for the healthcare market worldwide.The firm is valued at $5.33 billion. The firm operates through four divisions: Endoscopy, Water Purification and Filtration, Healthcare Disposables, and Dialysis.59.22 is the P/E ratio. The Endoscopy segment offers automated endoscope reprocessing systems; detergents; leak testing and manual cleaning products; storage cabinets; transport systems; mobile medical carts; endoscope process tracking products; other consumables, accessories, and supplies for use in disinfect rigid and flexible endoscopes, and other instrumentation; cleaning and disinfecting reusable components used in gastrointestinal endoscopy procedures; and technical maintenance services.

Cantel Medical Corp. (NYSE:CMD) Institutional Investors Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.




Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: